Cargando…

Correction: JAK inhibitors and COVID-19

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152002/ https://www.ncbi.nlm.nih.gov/pubmed/37117008 http://dx.doi.org/10.1136/jitc-2021-002838corr1

Ejemplares similares

Correction: Mutant JAK3 phosphoproteomic profiling predicts synergism between JAK3 inhibitors and MEK/BCL2 inhibitors for the treatment of T-cell acute lymphoblastic leukemia
por: Degryse, S., et al.
Publicado: (2018)

Correction Notice: Rapid Emergence of Chronic Lymphocytic Leukemia During JAK2 Inhibitor Therapy in a Patient With Myelofibrosis
Publicado: (2021)

JAK inhibitors and COVID-19
por: Levy, Gabriel, et al.
Publicado: (2022)

Author Correction: Targeting the NF-κB pathway enhances responsiveness of mammary tumors to JAK inhibitors
por: Bapat, Aditi S., et al.
Publicado: (2023)

Correction: On the use of immune checkpoint inhibitors in patients with viral infections including COVID-19
Publicado: (2021)

Correction: HCMV Activates the IL-6-JAK-STAT3 Axis in HepG2 Cells and Primary Human Hepatocytes
por: Lepiller, Quentin, et al.
Publicado: (2013)

Correction: Inhibition of the JAK/STAT Signaling Pathway in Regulatory T Cells Reveals a Very Dynamic Regulation of Foxp3 Expression
Publicado: (2016)

Correction: Piperlongumine Blocks JAK2-STAT3 to Inhibit Collagen-Induced Platelet Reactivity Independent of Reactive Oxygen Species(†)
por: Yuan, Hengjie, et al.
Publicado: (2016)

Correction: Arginine regulates inflammation response-induced by Fowl Adenovirus serotype 4 via JAK2/STAT3 pathway
por: Xiang, Silin, et al.
Publicado: (2022)

Correction to: The immunogenetics of COVID-19
por: Srivastava, Anshika, et al.
Publicado: (2023)

Correction to: On COVID-19 Modelling
por: Schaback, Robert
Publicado: (2021)

Author Correction: Recurrent PTPRT/JAK2 mutations in lung adenocarcinoma among African Americans
por: Mitchell, Khadijah A., et al.
Publicado: (2020)

Correction: The Synthetic α-Bromo-2′,3,4,4′-Tetramethoxychalcone (α-Br-TMC) Inhibits the JAK/STAT Signaling Pathway
Publicado: (2014)

Correction to: A novel miR-219-SMC4-JAK2/Stat3 regulatory pathway in human hepatocellular carcinoma
por: Zhou, Bo, et al.
Publicado: (2021)

Correction: A novel small molecule agent displays potent anti-myeloma activity by inhibiting the JAK2-STAT3 signaling pathway
por: Zhang, Zubin, et al.
Publicado: (2016)

Correction: Bruton's Agammaglobulinemia and COVID-19
por: Hovey, Justin G, et al.
Publicado: (2021)

Correction to: COVID‑19 and output in Japan
por: Fujii, Daisuke, et al.
Publicado: (2021)

Correction: Microfluidic Generated EGF-Gradients Induce Chemokinesis of Transplantable Retinal Progenitor Cells via the JAK/STAT and PI3Kinase Signaling Pathways
por: Unachukwu, Uchenna J., et al.
Publicado: (2014)

Correction: Cytokine Receptor-Like Factor 1 (CRLF1) Protects against 6-Hydroxydopamine Toxicity Independent of the gp130/JAK Signaling Pathway
por: Looyenga, Brendan D., et al.
Publicado: (2014)

Correction: Self-Renewal of Single Mouse Hematopoietic Stem Cells Is Reduced by JAK2V617F Without Compromising Progenitor Cell Expansion
Publicado: (2015)

Efficacy of Combination Therapy With The JAK Inhibitor Baricitinib In The Treatment of COVID-19
por: Thoms, Brendan Lawless, et al.
Publicado: (2021)

Efficacy of Combination Therapy with the JAK Inhibitor Baricitinib in the Treatment of COVID-19
por: Thoms, Brendan L., et al.
Publicado: (2022)

Correction: Relative bradycardia in patients with COVID-19
por: Jung, Lae-Young, et al.
Publicado: (2023)

Correction to: Remdesivir: A Review in COVID-19
por: Blair, Hannah A.
Publicado: (2023)

Correction to: The Covid-19 World: Learning or Downfall
por: Suoranta, Juha
Publicado: (2020)

Correction to: COVID-19: Pulse oximeters in the spotlight
por: Michard, Frederic, et al.
Publicado: (2020)

Correction to: Responding to COVID-19: What’s the Problem?
por: Lawrence, Roderick J.
Publicado: (2020)

Correction to: POC COVID-19 test for dentistry
Publicado: (2020)

Correction to: COVID-19 and importance of environmental sustainability
por: Arora, Naveen Kumar, et al.
Publicado: (2020)

Correction to: Science, ethics, responsibility and COVID-19
por: Lőw, Péter
Publicado: (2021)

Correction: Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US Veterans
Publicado: (2021)

Correction: Testosterone suppresses uropathogenic Escherichia coli invasion and colonization within prostate cells and inhibits inflammatory responses through JAK/STAT-1 signaling pathway
por: Ho, Chen-Hsun, et al.
Publicado: (2017)

Correction: Suppression of USP18 Potentiates the Anti-HBV Activity of Interferon Alpha in HepG2.2.15 Cells via JAK/STAT Signaling
por: Li, Lin, et al.
Publicado: (2016)

Correction: Repurposing dextromethorphan and metformin for treating nicotine-induced cancer by directly targeting CHRNA7 to inhibit JAK2/STAT3/SOX2 signaling
por: Wang, Lu, et al.
Publicado: (2021)

Correction to: CircNOL10 suppresses breast cancer progression by sponging miR-767-5p to regulate SOCS2/JAK/STAT signaling
por: Wang, Fang, et al.
Publicado: (2021)

Correction: Discovery of novel non-peptidic and non-covalent small-molecule 3CL(pro) inhibitors as potential candidate for COVID-19 treatment
por: Jiang, Zhidong, et al.
Publicado: (2023)

Correction: Recent progress in ferroptosis: inducers and inhibitors
por: Du, Yunxi, et al.
Publicado: (2023)

Correction: Functional Analysis of Hsp70 Inhibitors
por: Schlecht, Rainer, et al.
Publicado: (2013)

Correction to: Naturally occurring cell adhesion inhibitors
por: Takamatsu, Satoshi
Publicado: (2018)

Correction: Chronic immune checkpoint inhibitor pneumonitis
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_n1l5oevhrpl6qs97otl27ab8ne